This study systematically reviewed the relevant literature on ErbB/HER receptors and bladder cancer, to better understand the role of the four ErbB/HER receptors in bladder cancer and its effectiveness as a therapeutic target. This evidence concerns the gene EGFR and urinary bladder carcinoma.